Global Azithromycin Drug Market Size, Share and Trends Analysis Report, By Type (Oral, Injection, and Topical Ophthalmic), and By End-User (Hospitals and Drug Stores), Forecast (2022-2028)

The global azithromycin drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Azithromycin is an antibiotic that belongs to the antibacterial class. It is an antibiotic that’s used to treat infections caused by bacteria. Azithromycin is prescribed to treat infections of the lungs, sinuses, skin, and other body areas that are mild to moderate. It has the ability to prevent harmful bacteria from proliferating and can combat a wide spectrum of germs, including several members of the streptococcus family. The rising prevalence of bacterial infection is propelling the growth of the Azithromycin Market. For instance, Novemver 2019, according to Centers for Disease Control and Prevention, in the US, bacteria and fungus cause more than 2.8 million infections and 35,000 deaths each year
Azithromycin is a effective antibiotic that accumulates in the tissues for a longer period of time. Azithromycin also has immunomodulatory effects in chronic inflammatory diseases, and its ability to modulate host responses has allowed it to be used as a long-term treatment for severe ailments such cystic fibrosis, COPD, and asthma. These reasons have increased azithromycin use and demand. Another important aspect driving expansion is azithromycin’s demonstrated safety and efficacy. The increased use of azithromycin has improved the treatment of a number of community-acquired diseases. Its distinct pharmacokinetics and unrivalled adverse-effect profile have had a substantial impact on patient adherence throughout time.
Furthermore, as a result of urbanisation and the destruction of natural habitats, climate change, and changing ecosystems, the rate of emergence of infectious diseases has increased recently, and the population group most affected by these infectious diseases is people aged 65 and above, as they are more prone to infection due to their less responsive immune system, and thus the world’s growing geriatric population is further increasing the rate of emergence of infectious diseases. According to the United Nations’ World Population Ageing Highlight 2020 report, the global geriatric population is expected to grow from 727 million in 2020 to 1.5 billion by 2050. As a result of the ageing population, the prevalence of infectious disorders is predicted to rise, complementing the market’s expansion over the forecast period.
Due to rising preference for oral administration of azithromycin, which is easily absorbed on an empty stomach, the oral segment is predicted to account for the significant share in the global market. As due its high concentration in phagocytes, azithromycin is aggressively delivered to the site of infection. A single oral dose of azithromycin can sustain the requisite bacteriostatic level in infected tissues for several days, which is a major contributor to this segment’s growth.
To obtain a strong position in the market, major corporations are pursuing strategic initiatives such as mergers and acquisitions, joint ventures, partnerships, R&D operations, and product development. For instance, in Februray 2020, the US FDA has given Aurobindo Pharma final approval to manufacture and commercialise azithromycin tablets in the US. Azithromycin tablets will be to treat mild to moderate infections in patients. The approval was given in the dosage of 250 mg and 500 mg, respectively. Additionally, in March 2020, Pfizer announced positive results from a COVID-19 clinical trial in France, using its azithromycin (Zithromax) medication in combination with hydroxychloroquine.

 

Market Coverage
The market number available for – 2020-2028
Base year- 2020
Forecast period- 2022-2028
Segment Covered-
By Type
By End-User
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Top Major Key Players:
Pfizer, Lupin, Aurbindo Pharma, Jubliant Lifesciences Ltd., Korpan Ltd. And others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Azithromycin Drug Market Report by Segment
By Type
Oral
Injectable
Ophthalmic
By End-User
Online
Offline